SCHEMBL5433487

SCHEMBL5433487

Cc1ccc2oc(-c3ccc(O)cc3)cc(=O)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 5/20 1.00
CSNK2B P67870 5/20 1.00
CSNK2A1 P68400 5/20 1.00
MAPT P10636 6/20 0.77
CYP3A4 P08684 5/20 0.77
HPGD P15428 5/20 0.77
TP53 P04637 4/20 0.77
NPC1 O15118 4/20 0.77
RAB9A P51151 4/20 0.77
SMN1; SMN2 Q16637 3/20 0.77
IP6K2 Q9UHH9 2/20 0.77
LMNA P02545 1/20 0.77
THRB P10828 1/20 0.77
ALOX15 P16050 1/20 0.77
CASP3 P42574 1/20 0.77
SENP8 Q96LD8 1/20 0.77
SENP7 Q9BQF6 1/20 0.77
SENP6 Q9GZR1 1/20 0.77
KDM4E B2RXH2 5/20 0.73
ALDH1A1 P00352 4/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10305788 0.91 CSNK2A2 (1.00) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL10024074 0.91 CSNK2A2 (0.82) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL31741263 0.87 MAPT (1.00) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL311405 0.87 MAPT (1.00) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL4650552 0.85 CSNK2A2 (0.74) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
6-Methylflavone SCHEMBL4648879 0.84 TP53 (1.00) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
6-Methylflavone SCHEMBL29804485 0.84 TP53 (1.00) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL28043561 0.84 CSNK2A2 (0.72) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL5424662 0.84 CYP3A4 (0.79) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL535143 0.82 KCNA5 (1.00) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111039910-A Photoinitiated method for synthesizing 3-aryl flavone or coumarin compound and application thereof 云南大学 2020-04-21 CN disclosed
US-10208025-B2 Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2019-02-19 US disclosed
US-9611256-B2 Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2017-04-04 US disclosed
US-20170044141-A1 ALKYNE-, AZIDE- AND TRIAZOLE-CONTAINING FLAVONOIDS AS MODULATORS FOR MULTIDRUG RESISTANCE IN CANCERS THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2017-02-16 US disclosed
US-20150011513-A1 ALKYNE-, AZIDE- AND TRIAZOLE-CONTAINING FLAVONOIDS AS MODULATORS FOR MULTIDRUG RESISTANCE IN CANCERS THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2015-01-08 US disclosed
WO-2013127361-A1 ALKYNE-, AZIDE- AND TRIAZOLE-CONTAINING FLAVONOIDS AS MODULATORS FOR MULTIDRUG RESISTANCE IN CANCERS THE HONG KONG POLYTECHNIC UNIVERSITY (CN) 2013-09-06 WO disclosed
US-20070254859-A1 Compounds exhibiting efflux inhibitor activity and composition and uses thereof EASTMAN CHEMICAL COMPANY 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254859-A1 Compounds exhibiting efflux inhibitor activity and composition and uses thereof ABCC4, NCOA4, NR4A3 CSNK2A2 1259/4885CSNK2B 874/4885CSNK2A1 1238/4885
US-20170044141-A1 ALKYNE-, AZIDE- AND TRIAZOLE-CONTAINING FLAVONOIDS AS MODULATORS FOR MULTIDRUG RESISTANCE IN CANCERS ABCG2, ABCB1, ABCC1 CSNK2A2 4178/4885CSNK2B 4083/4885CSNK2A1 4214/4885
US-10208025-B2 Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers ABCG2, ABCB1, ABCC1 CSNK2A2 4178/4885CSNK2B 4083/4885CSNK2A1 4214/4885
US-20150011513-A1 ALKYNE-, AZIDE- AND TRIAZOLE-CONTAINING FLAVONOIDS AS MODULATORS FOR MULTIDRUG RESISTANCE IN CANCERS ABCG2, ABCB1, ABCC1 CSNK2A2 4178/4885CSNK2B 4083/4885CSNK2A1 4214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.